Samsung Biologics raises annual estimated earnings to W3.6t
Samsung Biologics has raised the full-year earnings estimate in its company guidance again to 3.6 trillion won ($2.6 billion) for this year, up some 20 percent from last year, according to its regulatory filing released on Wednesday.
It was the second time this year for Samsung Biologics to increase the estimate of its annual earnings. Earlier in April, the company raised its estimated earnings from sales to 3.52 trillion won.
“(Samsung Biologics) has readjusted (the estimated earnings in its) annual company guidance again, mainly based on large-sized contract manufacturing orders from international pharmaceutical companies this year,” an official from Samsung Biologics said.
In 2023, the company’s accumulated order value reached some 2.7 trillion won, backed by its large-scale contracts with Pfizer, Novartis and BMS.
Many of its clients, including GSK, Roche, Novartis, Pfizer and Eli Lilly, have also agreed with Samsung Biologics to expand their existing contract manufacturing deals, helping the company to post improved earnings this year.
The combined value of deals that have been expanded from existing deals has reached 986.2 billion won as of September, according to Samsung Biologics.
Samsung Biologics expects its earnings to improve particularly in the third quarter, in which revenue from the company’s fourth plant will start to be included.
“The utilization rate of the fourth plant has been increasing faster than expected,” the official from Samsung Biologics said.
(责任编辑:자동차)
- 김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
- More seniors working but still not earning enough: data
- Manpower Korea’s unique approach to reference checks
- 보란듯 제재 무시하며 국제법 준수?…김정은 활용하는 푸틴의 속내는
- Foreign workers' deaths get weak sanctions
- Intangible cultural heritage exhibitions, performances head overseas
- Seoul shares open lower on Fed, growth woes
- Young swimmer enjoys self
- GOT7’s Youngjae to release 1st solo LP “Do It” next month
- Trilateral talks open on Korea
- Auteur Chung Ji
- Young swimmer enjoys self
- 北, 日의 장거리미사일 조기 배치 추진에 “전쟁국가 일본 실체”
- Revamped Genesis GV80 and first coupe sibling unveiled
- [Korea Beyond Korea] In Paris, soaring demand for Korean studies yet to be fully met
- Opposition leader Lee attends arrest warrant hearing at Seoul court
- N. Korean envoy vows stronger 'self
- Seoul shares open lower on Fed, growth woes
- Import prices up for 3rd month in September on higher oil prices
- S. Korean fencer Oh Sang
- Apple under fire for ‘overpriced’ iPhones views+
- [Today’s K views+
- Questions raised over Taihan Cable’s quality control views+
- 한중 축구, 다음선 중국 응원이 91%…‘차이나 게이트’ 논란 views+
- Show must go on: 28th Busan International Film Festival kicks off despite setbacks views+
- Seoul shares open higher on Fed rate pause hopes views+